F-Star Therapeutics Inc
NASDAQ:FSTX
F-Star Therapeutics Inc
Other
F-Star Therapeutics Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F-Star Therapeutics Inc
NASDAQ:FSTX
|
Other
-$92k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other
-$527m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other
-$261m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
7%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other
-$134m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other
-$290.6m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other
-$947.3m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
N/A
|
See Also
What is F-Star Therapeutics Inc's Other?
Other
-92k
USD
Based on the financial report for Dec 31, 2021, F-Star Therapeutics Inc's Other amounts to -92k USD.